Use of cyclosporine for the treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis.
Publication
, Journal Article
Shah, R; Chen, ST; Kroshinsky, D
Published in: J Am Acad Dermatol
August 2021
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Am Acad Dermatol
DOI
EISSN
1097-6787
Publication Date
August 2021
Volume
85
Issue
2
Start / End Page
512 / 513
Location
United States
Related Subject Headings
- Young Adult
- Stevens-Johnson Syndrome
- Retrospective Studies
- Middle Aged
- Male
- Humans
- Female
- Dermatology & Venereal Diseases
- Cyclosporine
- Aged
Citation
APA
Chicago
ICMJE
MLA
NLM
Shah, R., Chen, S. T., & Kroshinsky, D. (2021). Use of cyclosporine for the treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis. J Am Acad Dermatol, 85(2), 512–513. https://doi.org/10.1016/j.jaad.2018.09.063
Shah, Radhika, Steven T. Chen, and Daniela Kroshinsky. “Use of cyclosporine for the treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis.” J Am Acad Dermatol 85, no. 2 (August 2021): 512–13. https://doi.org/10.1016/j.jaad.2018.09.063.
Shah R, Chen ST, Kroshinsky D. Use of cyclosporine for the treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis. J Am Acad Dermatol. 2021 Aug;85(2):512–3.
Shah, Radhika, et al. “Use of cyclosporine for the treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis.” J Am Acad Dermatol, vol. 85, no. 2, Aug. 2021, pp. 512–13. Pubmed, doi:10.1016/j.jaad.2018.09.063.
Shah R, Chen ST, Kroshinsky D. Use of cyclosporine for the treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis. J Am Acad Dermatol. 2021 Aug;85(2):512–513.
Published In
J Am Acad Dermatol
DOI
EISSN
1097-6787
Publication Date
August 2021
Volume
85
Issue
2
Start / End Page
512 / 513
Location
United States
Related Subject Headings
- Young Adult
- Stevens-Johnson Syndrome
- Retrospective Studies
- Middle Aged
- Male
- Humans
- Female
- Dermatology & Venereal Diseases
- Cyclosporine
- Aged